|Mr. Mark Ziirsen||CFO & Executive Chairman||93.92k||N/A||1963|
|Mr. Damon Rasheed||CTO & Executive Director||44.2k||N/A||N/A|
|Mr. Saurabh Jain||Interim CEO||N/A||N/A||N/A|
|Mr. Shane Lewis||Vice President of Sales & Partnerships||N/A||N/A||N/A|
|Mr. Scott Sorochak||Chief Revenue Officer||N/A||N/A||N/A|
|Mr. David Lilja M.B.A.||Company Secretary||N/A||N/A||N/A|
Opyl Limited develops digital tools that enhance healthcare experience for patients in Australia. The company also delivers deep market insights from social media data and enhance clinical research process. It offers Opin, a clinical trial recruitment platform that leverages social media, search engine optimization technologies and emerging artificial intelligence science, and matching patients directly to clinical trials. The company was formerly known as ShareRoot Limited and changed its name to Opyl Limited in December 2019. Opyl Limited was incorporated in 1994 and is based in St Kilda, Australia.
Opyl Limited’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.